modelJ01FA10

Diagram of J01FA10

Extends from Pharmacokinetic.Models.PK_2C_enteral.

Information

name:Azithromycin
ATC code:J01FA10
route:oral
compartments:2
dosage:500mg
volume of distribution:31.1L
clearance:630mL/min
other parameters in model implementation

Azithromycin is a macrolide antibiotic used primarily for the treatment of respiratory tract, skin, and soft tissue infections due to susceptible bacteria. It is also indicated for some sexually transmitted infections and is widely prescribed due to its long half-life and broad-spectrum activity. Azithromycin is approved for clinical use worldwide.

Pharmacokinetics

Pharmacokinetic parameters in healthy adult volunteers after single 500 mg oral dose.

References

  1. Unemo, M, et al., & Dillon, JR (2019). Gonorrhoea. Nature reviews. Disease primers 5(1) 79–None. DOI:10.1038/s41572-019-0128-6 PUBMED:https://pubmed.ncbi.nlm.nih.gov/31754194

  2. Zhang, XY, et al., & Lu, W (2010). Population pharmacokinetics study of azithromycin oral formulations using NONMEM. International journal of clinical pharmacology and therapeutics 48(10) 662–669. DOI:10.5414/cpp48662 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20875372

  3. Zhao, Q, et al., & Mould, DR (2014). Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets. Malaria journal 13 36–None. DOI:10.1186/1475-2875-13-36 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24472224

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)